Bjoern Albrecht

Bjoern Albrecht, Ph.D., serves as a Senior Partner at McKinsey & Company, where a notable career since 2003 has been marked by extensive work with top pharmaceutical and biotech clients in oncology across Europe, the USA, and Japan. Key achievements include the redefinition of over 15 business units, the establishment of early research strategies, and the acceleration of clinical development for more than 20 assets, alongside overseeing 25 product launches and integrating multi-billion dollar organizations. Prior experience includes a post-doctoral fellowship at New York University's Skirball Institute for Biomolecular Medicine, focusing on leukemia, lymphoma, and immuno-oncology. Educational qualifications comprise a Ph.D. in Molecular Oncology from The Ohio State University, alongside earlier studies in biochemistry and molecular biology.